Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

HMS faculty, help us improve the algorithms in Profiles by uploading your CV!

Joseph Frank Merola, M.D.


This page shows the publications co-authored by Joseph Merola and Seoyoung Kim.
Connection Strength

  1. Patient characteristics associated with use of TNF vs interleukin inhibitors as first-line biologic treatment for psoriatic arthritis. J Manag Care Spec Pharm. 2021 Aug; 27(8):1106-1117.
    View in: PubMed
    Score: 0.231
  2. Risk of Hospitalization for Serious Infection After Initiation of Ustekinumab or Other Biologics in Patients With Psoriasis or Psoriatic Arthritis. Arthritis Care Res (Hoboken). 2021 May 10.
    View in: PubMed
    Score: 0.227
  3. Validation of claims-based algorithms to identify patients with psoriasis. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):868-874.
    View in: PubMed
    Score: 0.225
  4. Dupilumab and the risk of conjunctivitis and serious infection in patients with atopic dermatitis: A propensity score-matched cohort study. J Am Acad Dermatol. 2021 Feb; 84(2):300-311.
    View in: PubMed
    Score: 0.218
  5. Risk of Inflammatory Arthritis After a New Diagnosis of Hidradenitis Suppurativa. JAMA Dermatol. 2020 03 01; 156(3):342-345.
    View in: PubMed
    Score: 0.209
  6. Patterns of Systemic Treatment for Psoriatic Arthritis in the US: 2004-2015. Arthritis Care Res (Hoboken). 2018 05; 70(5):791-796.
    View in: PubMed
    Score: 0.183
  7. Incidence of Venous Thromboembolism in Patients With Dermatologist-Diagnosed Chronic Inflammatory Skin Diseases. JAMA Dermatol. 2021 Jul 01; 157(7):805-816.
    View in: PubMed
    Score: 0.057
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.